Ambrx Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch AMAM and buy or sell other stocks, options, and ETFs commission-free!

About AMAM

Ambrx Biopharma, Inc. is a clinical-stage biologics company, which engages in discovering and developing a novel class of engineered precision biologics (EPBs). Using its proprietary expanded genetic code technology platform, it allows incorporating synthetic amino acids (SAAs) into proteins within living cells. 

CEO
Daniel J. O'Connor
CEODaniel J. O'Connor
Employees
66
Employees66
Headquarters
La Jolla, California
HeadquartersLa Jolla, California
Founded
2023
Founded2023
Employees
66
Employees66

AMAM Key Statistics

Market cap
1.73B
Market cap1.73B
Price-Earnings ratio
-13.86
Price-Earnings ratio-13.86
Dividend yield
Dividend yield
Average volume
311.84K
Average volume311.84K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$28.15
52 Week high$28.15
52 Week low
$6.55
52 Week low$6.55
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.